Back to results
US 2006/0233775 A1Published application
Selection and use of lactic acid bacteria for reducing inflammation in mammals
OwnerEamonn Connollyinventor
Life of this patent
Estimating the term…
Abstract
Strains of lactic acid bacteria selected for their capability of reducing inflammation, such as intestinal bowel disease, a method of selecting such strains, and products containing such strains
Claims7
A biologically pure culture of Lactobacillus reuteri ATCC PTA-6475.
A method for selecting a bacterial strain effective for treating inflammation in inflammatory bowel disease, comprising:
- using a THP-1 monocytic cell line from a human source, exposing the cell line to lipopolysaccharide and testing against supernatants from bacterial strains to be tested to identify a strain which is effective in decreasing TNFα.
Dependencies are inferred from the claim text.